The Australia Minimally Invasive Surgery Market was valued at $1411 Million in 2025 and projected to reach to $2667.7 Million by 2030, representing a compound annual growth rate of 13.6%. Australia's minimally invasive surgery market is positioned for sustained growth through 2030, driven by an aging population requiring surgical interventions and increasing healthcare expenditure across both public and private sectors.
Australia's minimally invasive surgery market is valued at USD 1,411.0 million in 2025, with projections reaching USD 2,667.7 million by 2030, demonstrating strong market expansion driven by technological adoption and healthcare investment.
Australia's rapidly aging demographic is a key growth driver, with an increasing elderly population requiring surgical interventions. This demographic shift is accelerating demand for minimally invasive procedures that offer reduced recovery times and lower complication rates.
Australian healthcare facilities are increasingly adopting cutting-edge surgical technologies and robotic-assisted systems. Major hospitals and private surgical centers across major cities are investing heavily in minimally invasive capabilities to enhance patient outcomes.
With a CAGR of 13.6% from 2025 to 2030, Australia's market growth outpaces many developed nations, reflecting strong healthcare spending, favorable reimbursement policies, and high patient awareness of minimally invasive surgical benefits.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | AMBULATORY SURGERY CENTERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 16.1% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 94.48 (2025) |
| Revenue Forecast (Billions) | ~USD 199.3 (2030) |
| Segments Covered | Type, Application, End User, Product |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BRUKER CORPORATION | United States | Public Company | BSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry, molecular diagnostics, automation, digital),BSI Nano (X-ray, AFM, electron microscopy tools, optical microscopy), |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
| JOHNSON & JOHNSON | United States | Public Company | Oncology & Immunology (Innovative Medicine),Neuroscience, Cardiovascular & Metabolism, Infectious Diseases,Surgery & Interventional Solutions (MedTech), |
| STRYKER | United States | Public Company | Orthopaedics Implants (Hip, Knee, Shoulder, Ankle, Trauma & Extremities),MedSurg Equipment & Patient Handling,Neurotechnology & Stroke / VTE Intervention, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, single-use scopes, infection prevention),MedSurg – Urology and Pelvic Health, |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| ZIMMER BIOMET | United States | Public Company | Knee and Hip Reconstructive Products,S.E.T. (Sports Medicine, Extremities, Trauma, CMF/T),Digital, Robotic, and Enabling Technologies (ROSA, ZBEdge, Bone Cement, Surgical Products), |
| GLOBUS MEDICAL | United States | Public Company | Spine fusion implants (pedicle screw and rod, plating, interbody, corpectomy),Motion preservation and interventional spine (disc replacement, dynamic stabilization, VCF solutions),Biologic solutions and HCT/P distribution, |
| INTEGRA LIFESCIENCES CORPORATION | United States | Public Company | Codman Specialty Surgical (neurosurgery and neurocritical care),Tissue Technologies – acute and chronic wound care,Tissue Technologies – surgical reconstruction and nerve/tendon repair, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| FUJIFILM CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, functional films, storage, industrial equipment),Business Innovation (office equipment, document services, graphic communications), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MRI, CT, X-ray, Ultrasound),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory),Image Guided Therapy Systems & Devices, |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
Bruker Corporation is a U.S.-based public company founded in 1960 that employs 11,085 people. The company specializes in scientific instruments and analytical solutions.
Medtronic is a public company headquartered in Ireland, founded in 1949, with 95,000 employees. It is a global leader in medical technology, services, and solutions.
Johnson & Johnson is a U.S.-based public company founded in 1886 with 138,200 employees. It operates across pharmaceuticals, medical devices, and consumer health products.
Stryker is a U.S. public company founded in 1941 with 56,000 employees. It is a leading provider of medical devices and software for orthopedic, surgical, and neurotechnology markets.
Boston Scientific Corporation is a U.S. public company founded in 1979 with 59,000 employees. It develops and manufactures medical devices for interventional medicine and patient monitoring.
Abbott is a U.S. public company founded in 1888 with 115,000 employees. It operates in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.
Zimmer Biomet is a U.S. public company founded in 1927 with 17,000 employees. It specializes in orthopedic implants, surgical products, and musculoskeletal healthcare solutions.
Globus Medical is a U.S. public company founded in 2003 with 6,000 employees. It develops and manufactures musculoskeletal implants and surgical instruments.
Integra LifeSciences Corporation is a U.S. public company founded in 1989 with 4,427 employees. It provides surgical implants, instruments, and regenerative medicine products.
Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees. It offers diagnostic imaging, laboratory diagnostics, and point-of-care testing solutions.
Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, information, and document solutions, including healthcare technologies.
Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees. It provides health technology solutions including diagnostic imaging, patient monitoring, and connected care.
GE Healthcare is a U.S. public company founded in 2022 with 54,000 employees. It provides medical imaging, monitoring, and diagnostic equipment and software solutions.
Australia's minimally invasive surgery market was valued at USD 1,411.0 million in 2025.
Australia's minimally invasive surgery market is forecast to reach USD 2,667.7 million by 2030.
Australia's minimally invasive surgery market is expected to grow at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2030.
Key drivers include Australia's aging population, rising prevalence of chronic diseases, advanced healthcare infrastructure, and increasing adoption of robotic-assisted and endoscopic procedures.
Australia's 13.6% CAGR is slightly below the global average of 16.1%, though Australia remains a significant regional market within Asia Pacific with strong healthcare spending and technology adoption.
The study involved key activities in estimating the current size of the minimally invasive surgery market. Extensive secondary research was conducted to gather information on the industry. The next step was to validate these findings, assumptions, and market size with industry experts across the value chain through primary research. Different methods, such as top-down and bottom-up approaches, were used to estimate the overall market size. Subsequently, market segmentation and data triangulation techniques were applied to determine the size of various segments and subsegments within the MIS market.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global minimally invasive surgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from various companies and organizations in the minimally invasive surgery market. On the demand side, primary sources include ambulatory surgical centers, hospitals, clinics, and other end users. The primary research was conducted to validate market segmentation, identify key players, and gather insights on important industry trends and market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were estimated based on revenue mapping of leading product manufacturers and OEMs active in the worldwide minimally invasive surgery market. All major product manufacturers were identified at the global and/or country or regional level. Revenue mapping for the respective business segments or sub-segments was performed for the key players. Also, the global minimally invasive surgery market was split into various segments and sub-segments based on:
The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After determining the overall size of the global minimally invasive surgery market using the methodology mentioned above, the market was divided into several segments and subsegments. Data triangulation and market breakdown techniques were used, where applicable, to complete the overall market analysis and obtain precise market value data for the key segments and subsegments. The extrapolated market data was then triangulated by examining various macro indicators and regional trends from both demand- and supply-side participants.
Minimally invasive surgery (MIS) is a procedure that causes little to no trauma or injury to a patient. MIS is performed through a cannula using lasers, endoscopes, or laparoscopes. It involves less bleeding, reduced anesthesia, less pain, and minimal scarring compared to other procedures. The surgical instruments used to make tiny incisions and carry out MIS are minimally invasive. The primary products used for minimally invasive surgery are surgical tools, imaging and visualization systems, electrosurgical devices, endoscopy devices, and medical robotics.
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Minimally Invasive Surgery Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report